You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Skip Main Navigation
Skip All Navigation
Albany Law Journal of Science and Technology
Considerations for the Off-Label Use of Medications in Oncology
19.0000000000000 ALB. L.J. SCI. & TECH. 557 (2009)
Sarah L. Scarpace
Practicing at the VA, one of our roles there is to really assess for the off-label use of medications whether or not there is enough evidence to support allowing a prescription to go through and reach a patient. And so we’re often in that situation where we’re trying to make a decision about a physician who would like to treat a patient with a medication that’s not indicated and we’re kind of the barrier. We’re one of the final people who are able to review that before allowing it to go through the system. So it’s definitely an issue that we deal with on a regular basis.